Ignite Creation Date:
2025-12-24 @ 12:57 PM
Ignite Modification Date:
2026-01-09 @ 11:30 PM
Study NCT ID:
NCT02468661
Status:
TERMINATED
Last Update Posted:
2020-02-24
First Post:
2015-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-01
First Submit QC Date:
None
Study First Post Date:
2015-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-20
Last Update Post Date:
2020-02-24
Last Update Post Date Type:
ACTUAL